Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant
PR94097
FLORENCE, Italy, Jan. 17, 2022 /PRNewswire=KYODO JBN/ --
The new Omicron variant is spreading rapidly causing an increase in infections
at unprecedented speed. On November 28th, WHO officially recommended
laboratories to use Real Time PCR detection kits capable of identifying
putative Omicron variant infections, directly at the moment of the positivity
test.
To support this recommendation, Menarini offers CoronaMeltVAR, a CE-IVD
Real-Time PCR kit based on intercalating dye and melting curve analysis. The
kit detects positive samples with high sensitivity, through the amplification
of two targets, both compatible with all variants and with the wild type form,
simultaneously revealing with distinct signals the suspect presence of Omicron
Variant BA.1, BA.2, as well as Alpha, Beta/Gamma and WT/Delta.
All responses are obtained in a single run on each sample, with no loss of
sensitivity compared to normal kits and without the need to perform a second
reflex test on positive samples. The kit is compatible with most RNA extraction
protocols and Real-Time PCR instruments capable of performing melting curve
analysis at moderate resolution. CoronaMeltVAR provides SARS CoV-2 CE IVD
detection and Omicron surveillance in less than 2 hours.
"We are extremely proud to have made this unique solution available so quickly.
It is helping healthcare professionals in providing a specific, rapid and
accurate solution for the diagnosis and identification of Covid-19 Omicron
variant", said Fabio Piazzalunga, General Manager & Global Head of A.Menarini
Diagnostics and Chairman/CEO of Menarini Silicon Biosystems.
A.Menarini Diagnostics, the Human Touch of Technology: more than 35 years
dedicated to helping healthcare professionals make safe and sustainable
diagnosis, improving the quality of life of people all over the world.
A.Menarini Diagnostics is part of the Menarini Pharmaceutical Group, founded in
1886. Today it is present in 140 countries throughout the world, it counts more
than 17,000 employees and has a 2020 turnover of € 3.750 billion.
Logo - https://mma.prnewswire.com/media/1584634/Menarini_Logo.jpg
Source: Menarini Industrie Farmaceutiche Riunite
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。